Literature DB >> 1315332

Examination of whether persistently indeterminate human immunodeficiency virus type 1 Western immunoblot reactions are due to serological reactivity with bovine immunodeficiency-like virus.

C A Whetstone1, K R Sayre, N L Dock, M J VanDerMaaten, J M Miller, E Lillehoj, S S Alexander.   

Abstract

The bovine lentivirus, known as bovine immunodeficiency-like virus (BIV), is genetically, structurally, and antigenically related to human immunodeficiency virus type 1 (HIV-1). It is not known whether sera from persons exposed to BIV proteins would show either positive or indeterminate reactivity on HIV-1 antibody tests. We used a BIV Western blot (immunoblot) analysis to examine human sera characterized as HIV-1 antibody positive, HIV-1 antibody negative, HIV-1 persistently indeterminate, HIV-1 p17 antibody positive only, HIV-1 p24 antibody positive only, human T-cell leukemia virus type 1 (HTLV-1) p19 antibody positive only, or HTLV-1 p24 antibody positive only. None of these sera were positive by Western blot to BIV-specific proteins. Many of these sera, however, displayed strong reactivities to bovine cell culture antigens on blots prepared from both mock-infected and BIV-infected cell cultures. The HIV-1 p17 and p24 antibody-positive and the HTLV-1 p19 and p24 antibody-positive sera were further examined by Western blot to bovine leukemia virus (BLV) and were found to be negative. We examined sera from laboratory personnel at risk for BIV exposure, including two laboratory workers who were exposed to BIV by accidental injection with BIV-infected cell culture material, and found no evidence of seroconversion to BIV-specific proteins. We tested 371 samples of fetal bovine sera, each sample representing serum pooled from one to three fetuses. All samples were negative by BIV Western blot. To date, we have not detected any human sera with antibody to BIV-specific proteins. Our data indicate that persistently indeterminate results on HIV-1 Western blot are not caused by a human antibody response to BIV proteins.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1315332      PMCID: PMC265158          DOI: 10.1128/jcm.30.4.764-770.1992

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  33 in total

1.  Isolation of a virus from cattle with persistent lymphocytosis.

Authors:  M J Van der Maaten; A D Boothe; C L Seger
Journal:  J Natl Cancer Inst       Date:  1972-12       Impact factor: 13.506

2.  Infection of human cell cultures with bovine visna virus.

Authors:  J A Georgiades; A Billiau; B Vanderschueren
Journal:  J Gen Virol       Date:  1978-02       Impact factor: 3.891

3.  Equine infectious anemia virus gag and pol genes: relatedness to visna and AIDS virus.

Authors:  R M Stephens; J W Casey; N R Rice
Journal:  Science       Date:  1986-02-07       Impact factor: 47.728

4.  Intracellular proteins of feline immunodeficiency virus and their antigenic relationship with equine infectious anaemia virus proteins.

Authors:  H F Egberink; J Ederveen; R C Montelaro; N C Pedersen; M C Horzinek; M J Koolen
Journal:  J Gen Virol       Date:  1990-03       Impact factor: 3.891

5.  Comparative evaluation of bovine immunodeficiency-like virus infection by reverse transcriptase and polymerase chain reaction.

Authors:  F Kashanchi; Z Q Liu; B Atkinson; C Wood
Journal:  J Virol Methods       Date:  1991 Feb-Mar       Impact factor: 2.014

6.  A western blot assay for the detection of antibodies to bovine immunodeficiency-like virus in experimentally inoculated cattle, sheep, and goats.

Authors:  C A Whetstone; M J VanDerMaaten; J M Miller
Journal:  Arch Virol       Date:  1991       Impact factor: 2.574

7.  Characterization and molecular cloning of a bovine lentivirus related to human immunodeficiency virus.

Authors:  M A Gonda; M J Braun; S G Carter; T A Kost; J W Bess; L O Arthur; M J Van der Maaten
Journal:  Nature       Date:  1987 Nov 26-Dec 2       Impact factor: 49.962

8.  Molecular cloning of feline immunodeficiency virus.

Authors:  R A Olmsted; A K Barnes; J K Yamamoto; V M Hirsch; R H Purcell; P R Johnson
Journal:  Proc Natl Acad Sci U S A       Date:  1989-04       Impact factor: 11.205

9.  Evaluation of atypical human immunodeficiency virus immunoblot reactivity in blood donors.

Authors:  N L Dock; H V Lamberson; T A O'Brien; D E Tribe; S S Alexander; B J Poiesz
Journal:  Transfusion       Date:  1988 Sep-Oct       Impact factor: 3.157

10.  Characterization of the serological cross-reactivity between glycoproteins of the human immunodeficiency virus and equine infectious anaemia virus.

Authors:  R C Montelaro; W G Robey; M D West; C J Issel; P J Fischinger
Journal:  J Gen Virol       Date:  1988-07       Impact factor: 3.891

View more
  4 in total

1.  Haematological and lymphocyte subset analyses in sheep inoculated with bovine immunodeficiency-like virus.

Authors:  R M Jacobs; H E Smith; C A Whetstone; D L Suarez; B Jefferson; V E Valli
Journal:  Vet Res Commun       Date:  1994       Impact factor: 2.459

2.  Detection of multiple retroviral infections in cattle and cross-reactivity of bovine immunodeficiency-like virus and human immunodeficiency virus type 1 proteins using bovine and human sera in a western blot assay.

Authors:  R M Jacobs; H E Smith; B Gregory; V E Valli; C A Whetstone
Journal:  Can J Vet Res       Date:  1992-10       Impact factor: 1.310

3.  Detection of equine infectious anemia viral RNA in plasma samples from recently infected and long-term inapparent carrier animals by PCR.

Authors:  J L Langemeier; S J Cook; R F Cook; K E Rushlow; R C Montelaro; C J Issel
Journal:  J Clin Microbiol       Date:  1996-06       Impact factor: 5.948

4.  Immunologic cross-reactivity between structural proteins of human T-cell lymphotropic virus type I and the blood stage of Plasmodium falciparum.

Authors:  R B Lal; D Rudolph; M P Alpers; A J Sulzer; Y P Shi; A A Lal
Journal:  Clin Diagn Lab Immunol       Date:  1994-01
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.